Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy

Although lymph node yield in NRG/RTOG 9601 did not show association with adverse outcomes in the entire cohort or either arm alone, there was significant association between lymph node yield and adverse outcomes when seminal vesicle invasion was present. The therapeutic benefit of extensive lymph node dissection remains uncertain but could be more relevant in higher risk patients.

Authors

Institutions

Publication Details

Journal
The Prostate
Published
2025-07-21
DOI
https://doi.org/10.1002/pros.70018
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy

William U. Shipley, Thomas M. Pisansky, Seth A. Rosenthal, Jeffry Simko et al.
The Prostate
Prostate Cancer Diagnosis and Treatment
article

Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy

William U. Shipley, Thomas M. Pisansky, Seth A. Rosenthal, Jeffry Simko, Robert Timothy Dess, Lyudmila DeMora, Howard M. Sandler, Emily Chan, Jason A. Efstathiou, Elizabeth Gore, Anthony Wong, Jean‐Paul Bahary, Himanshu Lukka, Kenneth L. Zeitzer, Felix Y. Feng, Alexander G. Balogh, Michael Kuettel, L.S. McGinnis, R.D. Lovett, Stephanie L. Pugh
article en

Abstract

Although lymph node yield in NRG/RTOG 9601 did not show association with adverse outcomes in the entire cohort or either arm alone, there was significant association between lymph node yield and adverse outcomes when seminal vesicle invasion was present. The therapeutic benefit of extensive lymph node dissection remains uncertain but could be more relevant in higher risk patients.

The ProstateVol. 85(14)
Cedars-Sinai Medical Center (US), Roswell Park Comprehensive Cancer Center (US), Mayo Clinic (US), Harvard University (US), Medical College of Wisconsin (US), University of Michigan (US), Thomas Jefferson University Hospital (US), Juravinski Cancer Centre (CA), Rutland Regional Medical Center (US), Massachusetts General Hospital (US), Michigan Center for Translational Pathology (US), Sutter Roseville Medical Center (US), Novant Health Presbyterian Medical Center (US), Centre Hospitalier de l’Université de Montréal (CA), NRG Oncology (US), Hamilton Health Sciences (CA), University of San Francisco (US), Stanford University (US)
NRG Oncology, National Cancer Institute
Openalex Percentile: Top 72%
Prostate Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.